跳至主要内容
临床试验/EUCTR2014-002210-23-DK
EUCTR2014-002210-23-DK进行中(未招募)1 期

Can local intramuscular botulinum toxin improve dysphagia in patients with myopathic dysphagia and constriction of the cricoid muscle?

Rigshospitalet0 个研究点目标入组 15 人开始时间: 2014年6月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 18-80 years old
  • IBM or OPMD
  • Signed informed consent
  • Stable dosing of immunemodulation
  • No other important reason for dysphagia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Involvement in other trial last 30 days
  • Medication or disease incompatible with botox
  • Botox allergy
  • Botox treatment within 6 mth
  • Pregnant or lactating

研究者

相似试验

Can local botulinum toxin improve swallowing... | 临床试验